Yusuf Dölen

1.2k total citations
21 papers, 977 citations indexed

About

Yusuf Dölen is a scholar working on Immunology, Oncology and Molecular Biology. According to data from OpenAlex, Yusuf Dölen has authored 21 papers receiving a total of 977 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Immunology, 6 papers in Oncology and 4 papers in Molecular Biology. Recurrent topics in Yusuf Dölen's work include Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (7 papers) and CAR-T cell therapy research (5 papers). Yusuf Dölen is often cited by papers focused on Immunotherapy and Immune Responses (9 papers), Immune Cell Function and Interaction (7 papers) and CAR-T cell therapy research (5 papers). Yusuf Dölen collaborates with scholars based in Netherlands, United States and Czechia. Yusuf Dölen's co-authors include Dicle Güç, Carl G. Figdor, Engin U. Akkaya, Ziya Köstereli, Yusuf Çakmak, Safacan Kölemen, A. Lale Doğan, Bilal Kılıç, Yavuz Dede and L.T. Yıldırım and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Angewandte Chemie International Edition and Advanced Functional Materials.

In The Last Decade

Yusuf Dölen

21 papers receiving 975 citations

Peers

Countries citing papers authored by Yusuf Dölen

Since Specialization

Citations

This map shows the geographic impact of Yusuf Dölen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yusuf Dölen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yusuf Dölen more than expected).

Fields of papers citing papers by Yusuf Dölen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yusuf Dölen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yusuf Dölen. The network helps show where Yusuf Dölen may publish in the future.

Co-authorship network of co-authors of Yusuf Dölen

This figure shows the co-authorship network connecting the top 25 collaborators of Yusuf Dölen. A scholar is included among the top collaborators of Yusuf Dölen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yusuf Dölen. Yusuf Dölen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	pH and ROS Responsiveness of Polymersome Nanovaccines for Antigen and Adjuvant Codelivery: An In Vitro and In Vivo Comparison 2024 ·Biomacromolecules ·Eliézer Jäger, Olga Ilina, Yusuf Dölen, Michael Valente, Eric A. W. van Dinther, Alessandro Jäger, Carl G. Figdor, Martijn Verdoes	5
2	Immunofilaments Are Well Tolerated after Local or Systemic Administration in Mice 2024 ·ACS Pharmacology & Translational Science ·L. Weiss, (unknown), (unknown), (unknown), Yusuf Dölen, (unknown), (unknown), (unknown), Kiek Verrijp, (unknown), (unknown), (unknown), Carl G. Figdor, Roel Hammink	1
3	Efficient targeting of NY-ESO-1 tumor antigen to human cDC1s by lymphotactin results in cross-presentation and antigen-specific T cell expansion 2022 ·Journal for ImmunoTherapy of Cancer ·Camille M. Le Gall, (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), (unknown), Yusuf Dölen, I. Jolanda M. de Vries, Carl G. Figdor, Georgina Flórez‐Grau, Martijn Verdoes	13
4	PLGA Nanoparticles Co-encapsulating NY-ESO-1 Peptides and IMM60 Induce Robust CD8 and CD4 T Cell and B Cell Responses 2021 ·Frontiers in Immunology ·Yusuf Dölen, Uzi Gileadi, Ji‐Li Chen, Michael Valente, Jeroen H. A. Creemers, Eric A. W. van Dinther, (unknown), Eliézer Jäger, Martin Hrubý, Vincenzo Cerundolo, Mustafa Diken, (unknown), I. Jolanda M. de Vries	30
5	Enhanced Antitumor Efficacy through an “AND gate” Reactive Oxygen‐Species‐Dependent pH‐Responsive Nanomedicine Approach 2021 ·Advanced Healthcare Materials ·Eliézer Jäger, (unknown), Yusuf Dölen, Jan Kučka, Alessandro Jäger, Rafał Konefał, Jan Pankrác, Ewa Pavlová, Tomáš Heizer, Luděk Šefc, Martin Hrubý, Carl G. Figdor, Martijn Verdoes	13
6	Nanovaccine administration route is critical to obtain pertinent iNKt cell help for robust anti-tumor T and B cell responses 2020 ·OncoImmunology ·Yusuf Dölen, Michael Valente, Oya Tagit, Eliézer Jäger, Eric A. W. van Dinther, (unknown), Martin Hrubý, Uzi Gileadi, Vincenzo Cerundolo, Carl G. Figdor	47
7	Multicore Liquid Perfluorocarbon‐Loaded Multimodal Nanoparticles for Stable Ultrasound and ¹⁹F MRI Applied to In Vivo Cell Tracking 2019 ·Advanced Functional Materials ·Olga Koshkina, Guillaume Lajoinie, Francesca Baldelli Bombelli, Edyta Swider, Luis J. Cruz, Paul B. White, Ralf Schweins, Yusuf Dölen, Eric A. W. van Dinther, (unknown), Sarah E. Rogers, Remco Fokkink, Ilja K. Voets, Ernst R. H. van Eck, Arend Heerschap, Michel Versluis, Chris L. de Korte, Carl G. Figdor, I. Jolanda M. de Vries, Mangala Srinivas	59
8	An efficient synthesis of a 6″-BODIPY-α-Galactosylceramide probe for monitoring α-Galactosylceramide uptake by cells 2019 ·Carbohydrate Research ·(unknown), (unknown), Yusuf Dölen, Martijn Verdoes, Mattie S. M. Timmer, Bridget L. Stocker	11
9	Intracellular Galectin-9 Controls Dendritic Cell Function by Maintaining Plasma Membrane Rigidity 2019 ·iScience ·(unknown), Oya Tagit, Yusuf Dölen, Anne van Duffelen, (unknown), Sonja I. Buschow, Toshiro Niki, Mitsuomi Hirashima, Ben Joosten, Koen van den Dries, Alessandra Cambi, Carl G. Figdor, Annemiek B. van Spriel	29
10	Microfluidics-Assisted Size Tuning and Biological Evaluation of PLGA Particles 2019 ·Pharmaceutics ·(unknown), Yusuf Dölen, (unknown), Eric A. W. van Dinther, Carl G. Figdor, Oya Tagit	39
11	Cross-talk between iNKT cells and CD8 T cells in the spleen requires the IL-4/CCL17 axis for the generation of short-lived effector cells 2019 ·Proceedings of the National Academy of Sciences ·Michael Valente, Yusuf Dölen, (unknown), Lene Vimeux, Mathieu Fallet, Vincent Feuillet, Carl G. Figdor	23
12	Injectable Biomimetic Hydrogels as Tools for Efficient T Cell Expansion and Delivery 2018 ·Frontiers in Immunology ·Jorieke Weiden, (unknown), Yusuf Dölen, Rajat Kumar Das, Anne van Duffelen, Roel Hammink, Loek J. Eggermont, Alan E. Rowan, Jurjen Tel, Carl G. Figdor	70
13	Endolysosomal‐Escape Nanovaccines through Adjuvant‐Induced Tumor Antigen Assembly for Enhanced Effector CD8⁺ T Cell Activation 2018 ·Small ·Liping Qiu, Michael Valente, Yusuf Dölen, Eliézer Jäger, Martin ter Beest, Liyan Zheng, Carl G. Figdor, Martijn Verdoes	34
14	Granulocytic subset of myeloid derived suppressor cells in rats with mammary carcinoma 2015 ·Cellular Immunology ·Yusuf Dölen, Gürcan Günaydın, Güneş Esendağlı, Dicle Güç	16
15	Co-delivery of PLGA encapsulated invariant NKT cell agonist with antigenic protein induce strong T cell-mediated antitumor immune responses 2015 ·OncoImmunology ·Yusuf Dölen, Martin Kreutz, Uzi Gileadi, Jurjen Tel, Angela Vasaturo, Eric A. W. van Dinther, Maaike A Van Hout-Kuijer, Vincenzo Cerundolo, Carl G. Figdor	61
16	Type I IFN‐mediated synergistic activation of mouse and human DC subsets by TLR agonists 2015 ·European Journal of Immunology ·Martin Kreutz, Ghaith Bakdash, Yusuf Dölen, Annette E. Sköld, Maaike A Van Hout-Kuijer, I. Jolanda M. de Vries, Carl G. Figdor	18
17	The effects of Cancer Associated Fibroblasts on mechanisms of immune evasion in a rat chemical mammary carcinoma model 2013 ·Frontiers in Immunology ·Gürcan Günaydın, Yusuf Dölen, Neşe Ünver, (unknown), Dicle Güç	3
18	Designing Excited States: Theory‐Guided Access to Efficient Photosensitizers for Photodynamic Action 2011 ·Angewandte Chemie International Edition ·Yusuf Çakmak, Safacan Kölemen, (unknown), Yavuz Dede, Yusuf Dölen, Bilal Kılıç, Ziya Köstereli, L.T. Yıldırım, A. Lale Doğan, Dicle Güç, Engin U. Akkaya	379
19	Designing Excited States: Theory‐Guided Access to Efficient Photosensitizers for Photodynamic Action 2011 ·Angewandte Chemie ·Yusuf Çakmak, Safacan Kölemen, (unknown), Yavuz Dede, Yusuf Dölen, Bilal Kılıç, Ziya Köstereli, L.T. Yıldırım, A. Lale Doğan, Dicle Güç, Engin U. Akkaya	67
20	Endothelial nitric oxide synthase gene polymorphism in gastric cancer 2010 ·The Turkish Journal of Gastroenterology ·(unknown), Halil Gürhan Karabulut, Güvem Gümüş‐Akay, Yusuf Dölen, Atilla Halil Elhan, Ajlan Tükün, Ali Ekrem Ünal	17

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact